H.R. 242 115th Congress House

Medicare Prescription Drug Price Negotiation Act of 2017

Official title: To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.

Introduced: January 4, 2017 Introduced by: Peter Welch Democratic · Vermont See on congress.gov

Health Health care costs and insuranceInflation and pricesMedicarePrescription drugsPublic contracts and procurement

Everywhere this bill has been 4 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jan 25, 2017

Referred to the Subcommittee on Health.

Jan 13, 2017

Referred to the Subcommittee on Health.

Jan 4, 2017

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jan 4, 2017

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action January 25, 2017

Referred to the Subcommittee on Health.

Plain-English summary Congressional Research Service

Medicare Prescription Drug Price Negotiation Act of 2017

This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.

Related & companion bills 3

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 4

Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Ways and Means Committee
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Ways and Means Committee
House of Representatives

Cosponsors 24

Carbajal, Salud O.

California · Oct 12, 2018

Ruiz, Raul

California · Sep 6, 2018

Khanna, Ro

California · Jul 26, 2018

Wasserman Schultz, Debbie

Florida · Jul 26, 2018

Gallego, Ruben

Arizona · Mar 26, 2018

Rooney, Francis

· Mar 26, 2018

Takano, Mark

California · Mar 26, 2018

Garamendi, John

California · Jul 19, 2017

Lofgren, Zoe

California · Jun 13, 2017

Suozzi, Thomas R.

New York · Jun 13, 2017

Pingree, Chellie

Maine · May 23, 2017

Sherman, Brad

California · May 23, 2017

VISCLOSKY, PETER

· May 3, 2017

Huffman, Jared

California · May 2, 2017

Raskin, Jamie

Maryland · Apr 28, 2017

Castor, Kathy

Florida · Jan 4, 2017

Cohen, Steve

Tennessee · Jan 4, 2017

DeLauro, Rosa L.

Connecticut · Jan 4, 2017

Kaptur, Marcy

Ohio · Jan 4, 2017

Lujan Grisham, Michelle

· Jan 4, 2017

Lynch, Stephen F.

Massachusetts · Jan 4, 2017

McCollum, Betty

Minnesota · Jan 4, 2017

Pocan, Mark

Wisconsin · Jan 4, 2017

Schakowsky, Janice D.

Illinois · Jan 4, 2017

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 242: Medicare Prescription Drug Price Negotiation Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-242/

MLA

"H.R. 242: Medicare Prescription Drug Price Negotiation Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-242/.

Bluebook (legal)

H.R. 242, 115th Cong. (2026), https://openamerica.io/bill/115-HR-242/.

Markdown link

[H.R. 242: Medicare Prescription Drug Price Negotiation Act of 2017](https://openamerica.io/bill/115-HR-242/)